Stephen Taub Cormorant Eyes Three IPOs This Week, Betting on Recent Success More than a half-dozen firms, known for their hedge funds, have previously made investments in the biopharma companies. Stephen Taub June 21, 2021 Bihua Chen, CEO of Cormorant Asset Management (Alex Flynn/Bloomberg)